Boston Scientific Corporation announced that an independent meta-analysis of more than 3,500 patients from five clinical ...
A stent designed to dissolve after it completes its task of propping open narrowed heart arteries is being tested by scientists. The first human experiment with the dissolving stent is being conducted with 26 patients at hospitals in New Zealand and Europe, the Associated Press reported. The study is designed to test whether the stent is safe enough to be used in larger studies.
ev3 Inc. has announced a worldwide fracture-free guarantee in support of its new EverFlex family of stents. In the event ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
Radiofrequency ablation is more effective than treatment with amiodarone for the prevention of atrial flutter recurrence in patients who experienced a first symptomatic episode, according to the results of a new study. In addition to the superiority of ablation over amiodarone, there was no increased risk of atrial fibrillation, even in this cohort of older patients, report investigators.
CoreValve announced that its patented ReValving System, consisting of a 18F delivery catheter, was used to percutaneously implant its proprietary porcine pericardial-tissue bioprosthesis over the severely calcified aortic heart valve of an 89-year-old woman.
When it comes to opening blocked carotid arteries, surgery may be less risky than stents according to a study by French doctors including Jean-Louis Mas, M.D., of the Hospitaux Sainte-Anne in Paris.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
Obesity and the illnesses associated with it cost the U.S. some 90.7 billion dollars a year in health care costs, a University of Pennsylvania researcher said. Among developed countries, the U.S. has the most obese and overweight people, representing 66 percent of its overall population.
A new program designed to provide hospitals with practical tools to help them reduce door-to-balloon times in STEMI ...
Reuters reports that seniors with diabetes are twice as likely to die from cardiovascular disease than non-diabetics, according to researchers from Kaiser Permanente in Tucker, GA.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
The new Fetch Aspiration Catheter from Possis Medical, Inc. has received 510(k) clearance from the FDA. Employing ...
A test designed to measure the durability of CoreValve’s ReValving device reached 200 million cycles, the company has reported. CoreValve’s chairman, CEO and founder, Dr. Jacques Seguin, says initial findings indicate its proprietary porcine pericardium aortic heart valve behaves, in vitro, better than tissue valves.
First U.S. installations of Volcano Corp.’s s5i IVUS (intravascular ultrasound) imaging system have been completed at ...
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
Boston Scientific has European CE clearance to begin marketing a private-label XIENCE V everolimus-eluting coronary ...
Berchtold Corp. has announced the introduction of the ChromoView Dual Flat-Panel (DFP) monitor mount and arm, a system that supports big images in a small space.
New technology for the Stellant D CT Injection System from MEDRAD is designed to improve timing for cardiac CT imaging ...